Efficacy and safety of certolizumab pegol monotherapy every 4 weeks in patients with rheumatoid arthritis failing previous disease-modifying antirheumatic therapy: the FAST4WARD study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples